Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQIndustrialsIndustrial - Pollution & Treatment ControlsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for PCT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
CAPEX stays within $39-$45 million in 2026 | It plans to control capital spending between $39-$45 million. | Intact | CAPEX exceeds $45 million in FY26 | Capital expenditures: $31.744M FY2026-Q2; GAAP. Published target: <= $45 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 6, 202631,744,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This investment represents a turnaround story with a focus on revenue growth and capital allocation. The current thesis state is cautious, given the company's recent financial performance and volatility in management execution.
The market seems to have priced in a significant premium compared to peers, reflecting uncertainty about future performance. There is a low confidence in valuation models, indicating that expectations may be fragile.
Fundamentals are likely to remain under pressure in the near term, especially given the company's history of missing earnings expectations. However, management's focus on revenue growth and capital allocation could support a gradual improvement if executed well.
The long-term thesis hinges on the company's ability to maintain revenue growth and manage capital effectively. Additionally, the performance of sector bellwethers will be crucial in determining the overall momentum in the Industrials sector.
In the next 1 to 3 years, PCT faces significant challenges but has potential if management can execute on its priorities. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company is raising $250 million in convertible notes and $145 million in stock. |
| Improving |
| Failure to complete planned capital raises within 1 year |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue reaches $10-$12 million in 2026 | A primary condition in PureCycle Technologies, Inc.'s published investment case. The stated target is >= $10 million. | Improving | Revenue falls below $10 million in FY26 | Revenue: $2.349M FY2026-Q3; GAAP. Published target: >= $10 million. Annual target cannot be compared with a quarterly or TTM observation. Nov 4, 20262,349,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.80 → $-0.59 · observed estimates
$0.12B → $0.11B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.80 | $116,525,000 | 4 / 6 |
| 2026-07-25 | $-0.80 | $116,525,000 | 4 / 6 |
| 2026-07-26 | $-0.80 | $116,525,000 | 4 / 6 |
| 2026-07-27 | $-0.80 | $116,525,000 | 4 / 6 |
| 2026-07-28 | $-0.80 | $116,525,000 | 4 / 6 |
| 2026-07-29 | $-0.80 | $116,525,000 | 4 / 6 |
| 2026-07-30 | $-0.80 | $116,525,000 | 4 / 6 |
| 2026-07-31 | $-0.69 | $116,518,050 | 5 / 5 |
| 2026-08-01 | $-0.69 | $116,518,050 | 5 / 5 |
| 2026-08-02 | $-0.80 | $117,570,000 | 4 / 5 |
| 2026-08-03 | $-0.80 | $117,570,000 | 4 / 5 |
| 2026-08-04 | $-0.80 | $117,570,000 | 4 / 5 |
| 2026-08-05 | $-0.69 | $116,518,050 | 5 / 5 |
| 2026-08-06 | $-0.69 | $116,518,050 | 5 / 5 |
| 2026-08-07 | $-0.67 | $117,561,660 | 4 / 4 |
| 2026-08-08 | $-0.67 | $117,561,660 | 4 / 4 |
| 2026-08-09 | $-0.78 | $117,570,000 | 4 / 5 |
| 2026-08-10 | $-0.78 | $117,570,000 | 4 / 5 |
| 2026-08-12 | $-0.67 | $117,561,660 | 4 / 4 |
| 2026-08-13 | $-0.67 | $117,561,660 | 4 / 4 |
| 2026-08-14 | $-0.67 | $117,561,660 | 4 / 4 |
| 2026-08-15 | $-0.67 | $117,561,660 | 4 / 4 |
| 2026-08-16 | $-0.67 | $117,561,660 | 4 / 3 |
| 2026-08-17 | $-0.67 | $117,561,660 | 4 / 3 |
| 2026-08-18 | $-0.67 | $117,561,660 | 4 / 4 |
| 2026-08-19 | $-0.67 | $117,561,660 | 4 / 4 |
| 2026-08-20 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-08-21 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-08-22 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-08-23 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-08-24 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-08-25 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-08-26 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-08-27 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-08-28 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-08-29 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-08-30 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-08-31 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-01 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-02 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-03 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-04 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-05 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-06 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-07 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-08 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-09 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-10 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-11 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-12 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-13 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-14 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-15 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-16 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-17 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-18 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-19 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-20 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-21 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-22 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-23 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-24 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-25 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-26 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-27 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-28 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-29 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-09-30 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-01 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-02 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-03 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-04 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-05 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-06 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-07 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-08 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-09 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-10 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-11 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-12 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-13 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-14 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-15 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-16 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-17 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-18 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-19 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-20 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-21 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-22 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-23 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-24 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-25 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-26 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-27 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-28 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-29 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-30 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-10-31 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-11-01 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-11-02 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-11-03 | $-0.59 | $112,054,800 | 4 / 4 |
| 2026-11-04 | $-0.59 | $112,054,800 | 4 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.